Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.

Article  PubMed  Google Scholar 

Yeh TS, Wang JD, Ku LE. Estimating life expectancy and lifetime healthcare costs for Alzheimer’s disease in Taiwan: Does the age of disease onset matter? J Alzheimers Dis. 2020;73(1):307–15.

Article  PubMed  Google Scholar 

GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88–106.

GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.

Lee SI, Cooper J, Fenton A, Subramanian A, Taverner T, Gokhale KM, et al. Decreased renal function is associated with incident dementia: An IMRD-THIN retrospective cohort study in the UK. Alzheimers Dement. 2022.

Xu H, Garcia-Ptacek S, Trevisan M, Evans M, Lindholm B, Eriksdotter M, et al. Kidney function, kidney function decline, and the risk of dementia in older adults: a registry-based study. Neurology. 2021;96(24):e2956–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46.

Article  PubMed  PubMed Central  Google Scholar 

Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, et al. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis : an individual participant-based meta-analysis. Ann Intern Med. 2020;173(6):426–35.

Article  PubMed  PubMed Central  Google Scholar 

Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function–measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473–83.

Article  CAS  PubMed  Google Scholar 

Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020;16(8):452–69.

Article  PubMed  Google Scholar 

Miranda AS, Cordeiro TM, Dos Santos Lacerda Soares TM, Ferreira RN, Simões ESAC. Kidney-brain axis inflammatory cross-talk: from bench to bedside. Clin Sci (Lond). 2017;131(11):1093–105.

Deckers K, Camerino I, van Boxtel MP, Verhey FR, Irving K, Brayne C, et al. Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies. Neurology. 2017;88(2):198–208.

Article  PubMed  PubMed Central  Google Scholar 

Scheppach JB, Coresh J, Wu A, Gottesman RF, Mosley TH, Knopman DS, et al. Albuminuria and estimated GFR as risk factors for dementia in midlife and older age: findings from the ARIC study. Am J Kidney Dis. 2020;76(6):775–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Ding D, Zhao Q, Wu W, Xiao Z, Liang X, et al. Kidney function and dementia risk in community-dwelling older adults: the Shanghai Aging Study. Alzheimers Res Ther. 2021;13(1):21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koop-Nieuwelink C, Sedaghat S, Mutlu U, Licher S, Franco OH, Ikram MA, et al. Kidney function and the risk of stroke and dementia: the Rotterdam study. J Alzheimers Dis. 2019;67(3):821–6.

Article  CAS  PubMed  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Working Group. Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3(1):19–62.

Masson P, Webster AC, Hong M, Turner R, Lindley RI, Craig JC. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(7):1162–9.

Article  CAS  PubMed  Google Scholar 

Singh-Manoux A, Oumarou-Ibrahim A, Machado-Fragua MD, Dumurgier J, Brunner EJ, Kivimaki M, et al. Association between kidney function and incidence of dementia: 10-year follow-up of the Whitehall II cohort study. Age Ageing. 2022;51(1):afab259.

Hsu CC, Kao WH, Coresh J, Pankow JS, Marsh-Manzi J, Boerwinkle E, et al. Apolipoprotein E and progression of chronic kidney disease. JAMA. 2005;293(23):2892–9.

Article  CAS  PubMed  Google Scholar 

Chu AY, Parekh RS, Astor BC, Coresh J, Berthier-Schaad Y, Smith MW, et al. Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study. BMC Med Genet. 2009;10:108.

Article  PubMed  PubMed Central  Google Scholar 

Xue C, Nie W, Tang D, Yi L, Mei C. Apolipoprotein E gene variants on the risk of end stage renal disease. PLoS One. 2013;8(12): e83367.

Article  PubMed  PubMed Central  Google Scholar 

Andrews SJ, Fulton-Howard B, Goate A. Interpretation of risk loci from genome-wide association studies of Alzheimer’s disease. Lancet Neurol. 2020;19(4):326–35.

Article  PubMed  PubMed Central  Google Scholar 

Baker E, Escott-Price V. Polygenic risk scores in Alzheimer’s disease: current applications and future directions. Front Digit Health. 2020;2:14.

Article  PubMed  PubMed Central  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3): e1001779.

Article  PubMed  PubMed Central  Google Scholar 

Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234–44.

Article  PubMed  Google Scholar 

Allen NE, Arnold M, Parish S, Hill M, Sheard S, Callen H, et al. Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank. Wellcome Open Res. 2020;5:222.

Article  PubMed  Google Scholar 

Fry D AR, Gordon M, Moffat S. UK Biobank biomarker project: details of assays and quality control information for the urinary biomarker data.

Fry D AR, Moffat S, Gordon M, Singh P. UK Biobank biomarker project: companion document to accompany serum biomarker data.

Wilkinson T, Schnier C, Bush K, Rannikmäe K, Henshall DE, Lerpiniere C, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34(6):557–65.

Article  PubMed  PubMed Central  Google Scholar 

Lövdén M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM. Education and cognitive functioning across the life span. Psychol Sci Public Interest. 2020;21(1):6–41.

Article  PubMed  PubMed Central  Google Scholar 

Durazzo TC, Mattsson N, Weiner MW. Smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement. 2014;10(3 Suppl):S122–45.

PubMed  PubMed Central  Google Scholar 

Littlejohns TJ, Collister JA, Liu X, Clifton L, Tapela NM, Hunter DJ. Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia. Alzheimers Dement. 2022.

Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North (1st ed.). Routledge; 1988. https://doi.org/10.4324/9781003368885.

Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ebenau JL, van der Lee SJ, Hulsman M, Tesi N, Jansen IE, Verberk IMW, et al. Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score. Alzheimers Dement (Amst). 2021;13(1): e12229.

Article  PubMed  Google Scholar 

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.

Article  PubMed  Google Scholar 

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280–92.

Article  PubMed  PubMed Central  Google Scholar 

Kang MW, Park S, Lee S, Lee Y, Cho S, Han K, et al. Glomerular hyperfiltration is associated with dementia: A nationwide population-based study. PLoS One. 2020;15(1): e0228361.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology. 2011;77(23):2043–51.

Article  CAS  PubMed  Google Scholar 

O’Hare AM, Walker R, Haneuse S, Crane PK, McCormick WC, Bowen JD, et al. Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc. 2012;60(12):2215–22.

Article  PubMed  PubMed Central  Google Scholar 

Gabin JM, Romundstad S, Saltvedt I, Holmen J. Moderately increased albuminuria, chronic kidney disease and incident dementia: the HUNT study. BMC Nephrol. 2019;20(1):261.

Article  PubMed  PubMed Central  Google Scholar 

Takae K, Hata J, Ohara T, Yoshida D, Shibata M, Mukai N, et al. Albuminuria increases the risks for both Alzheimer disease and vascular dementia in community-dwelling Japanese elderly: the Hisayama study. J Am Heart Assoc. 2018;7(2):e006693.

Wu XR, Wu KM, Deng YT, Huang SY, Yang L, Dong Q, et al. Association of kidney function with risk of incident dementia: a prospective cohort study of 275,167 UK Biobank Participants. J Alzheimers Dis. 2022;90(3):1249–61.

Article  CAS  PubMed